21.25
price down icon1.80%   -0.39
after-market アフターアワーズ: 21.33 0.08 +0.38%
loading
前日終値:
$21.64
開ける:
$21.95
24時間の取引高:
193.18K
Relative Volume:
0.60
時価総額:
$1.26B
収益:
-
当期純損益:
$-147.32M
株価収益率:
-4.0297
EPS:
-5.2733
ネットキャッシュフロー:
$-122.10M
1週間 パフォーマンス:
-1.21%
1か月 パフォーマンス:
+3.51%
6か月 パフォーマンス:
+33.48%
1年 パフォーマンス:
+189.12%
1日の値動き範囲:
Value
$21.07
$21.95
1週間の範囲:
Value
$20.35
$23.04
52週間の値動き範囲:
Value
$7.26
$26.18

Dbv Technologies Adr Stock (DBVT) Company Profile

Name
名前
Dbv Technologies Adr
Name
セクター
Healthcare (1112)
Name
電話
33(0)155427878
Name
住所
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Name
職員
125
Name
次回の収益日
2026-04-10
Name
最新のSEC提出書
Name
DBVT's Discussions on Twitter

Compare DBVT vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
DBVT icon
DBVT
Dbv Technologies Adr
21.25 1.28B 0 -147.32M -122.10M -5.2733
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
441.70 113.01B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
753.93 79.87B 14.34B 4.50B 3.77B 41.56
ARGX icon
ARGX
Argen X Se Adr
840.87 51.51B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
333.39 45.29B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
319.94 34.41B 5.36B 287.73M 924.18M 2.5229

Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-12-15 開始されました Cantor Fitzgerald Overweight
2025-12-03 開始されました Guggenheim Buy
2025-05-29 再開されました Goldman Sell
2023-01-04 アップグレード Societe Generale Hold → Buy
2022-12-16 ダウングレード Goldman Neutral → Sell
2022-05-10 ダウングレード Goldman Buy → Neutral
2021-09-14 アップグレード Societe Generale Hold → Buy
2021-01-22 ダウングレード Societe Generale Hold → Sell
2020-11-02 アップグレード Societe Generale Sell → Hold
2020-08-06 ダウングレード Societe Generale Buy → Sell
2020-08-05 繰り返されました H.C. Wainwright Buy
2020-03-17 ダウングレード Stifel Buy → Hold
2020-01-09 アップグレード Stifel Hold → Buy
2019-12-16 開始されました Citigroup Buy
2019-09-05 再開されました Morgan Stanley Equal-Weight
2019-06-17 開始されました Goldman Buy
2018-12-20 ダウングレード Barclays Overweight → Equal Weight
2018-12-20 ダウングレード BofA/Merrill Buy → Underperform
2018-12-20 ダウングレード Jefferies Buy → Hold
2018-12-20 ダウングレード Stifel Buy → Hold
2017-10-31 アップグレード Societe Generale Sell → Hold
2017-10-24 ダウングレード Societe Generale Buy → Sell
2017-10-23 ダウングレード Morgan Stanley Overweight → Equal-Weight
2017-06-23 開始されました Deutsche Bank Buy
2017-03-16 アップグレード Societe Generale Hold → Buy
2016-09-26 開始されました JMP Securities Mkt Outperform
2015-12-03 開始されました Barclays Overweight
2015-10-23 開始されました BofA/Merrill Buy
すべてを表示

Dbv Technologies Adr (DBVT) 最新ニュース

pulisher
Apr 13, 2026

Eosinophilic Esophagitis Market in the US to Grow at 13.2% CAGR During the Forecast Period (2026–2036) Owing to the Emergence of Drug Classes Such as TSLP Inhibitors, Glucocorticoid Receptor Agonists, and Immunomodulators | DelveInsight - GlobeNewswire Inc.

Apr 13, 2026
pulisher
Apr 11, 2026

Goldman Sachs Keeps Their Sell Rating on DBV Technologies SA – American (DBVT) - The Globe and Mail

Apr 11, 2026
pulisher
Apr 07, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Apr 07, 2026
pulisher
Apr 03, 2026

DBV technologies S.A. (ADR) (DBV1.SG) Stock Forum & Discussion - Yahoo! Finance Canada

Apr 03, 2026
pulisher
Apr 03, 2026

DBV technologies S.A. (ADR) (DBV1.SG) Stock Major Holders - Yahoo! Finance Canada

Apr 03, 2026
pulisher
Apr 03, 2026

DBV Technologies (DBVT) Projected to Post Quarterly Earnings on Friday - Defense World

Apr 03, 2026
pulisher
Apr 02, 2026

DBV technologies S.A. (ADR) (DBV1.SG) company profile and facts - Yahoo Finance UK

Apr 02, 2026
pulisher
Mar 29, 2026

Guggenheim Reiterates “Buy” Rating for DBV Technologies (NASDAQ:DBVT) - Defense World

Mar 29, 2026
pulisher
Mar 27, 2026

Alphabet To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga

Mar 27, 2026
pulisher
Mar 26, 2026

DBV Technologies Reports Full Year 2025 Financial Results and Business Update - markets.businessinsider.com

Mar 26, 2026
pulisher
Mar 26, 2026

DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document - The Manila Times

Mar 26, 2026
pulisher
Mar 26, 2026

DBV Technologies (NASDAQ: DBVT) deepens 2025 loss but funds runway into 2027 - Stock Titan

Mar 26, 2026
pulisher
Mar 25, 2026

Hesai Group, BitFuFu And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Sahm

Mar 25, 2026
pulisher
Mar 25, 2026

DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review - The Manila Times

Mar 25, 2026
pulisher
Mar 09, 2026

DLD Asset Management LP Makes New $250,000 Investment in DBV Technologies S.A. $DBVT - Defense World

Mar 09, 2026
pulisher
Mar 07, 2026

Analysts Offer Insights on Healthcare Companies: ArriVent BioPharma, Inc. (AVBP), Chemomab Therapeutics (CMMB) and Reviva Pharmaceuticals Holdings (RVPH) - The Globe and Mail

Mar 07, 2026
pulisher
Mar 05, 2026

DBV Technologies to Participate in Upcoming March Investor Conferences - The Manila Times

Mar 05, 2026
pulisher
Mar 04, 2026

Biotech DBV Technologies lines up back-to-back March investor events - Stock Titan

Mar 04, 2026
pulisher
Mar 03, 2026

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026 - ChartMill

Mar 03, 2026
pulisher
Mar 03, 2026

Guggenheim Sticks to Their Buy Rating for DBV Technologies SA – American (DBVT) - The Globe and Mail

Mar 03, 2026
pulisher
Mar 02, 2026

DBV Technologies stock surges on new peanut patch trial data - Investing.com

Mar 02, 2026
pulisher
Mar 02, 2026

Phase 3 VITESSE data highlighted by DBV Technologies (NASDAQ: DBVT) - Stock Titan

Mar 02, 2026
pulisher
Mar 01, 2026

DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting - The Manila Times

Mar 01, 2026
pulisher
Feb 28, 2026

DBV Technologies Highlights Additional Data from Successful - GlobeNewswire

Feb 28, 2026
pulisher
Feb 26, 2026

DBV Technologies (DBVT) Projected to Post Earnings on Thursday - Defense World

Feb 26, 2026
pulisher
Feb 25, 2026

European ADRs Were Flat As Biotech Names Took The Lead - Finimize

Feb 25, 2026
pulisher
Feb 25, 2026

Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA) and Palvella Therapeutics (PVLA) - The Globe and Mail

Feb 25, 2026
pulisher
Feb 24, 2026

DBV Technologies launches $150M ATM offering - MSN

Feb 24, 2026
pulisher
Feb 17, 2026

BioImpact LLC reports 9.99% DBV Technologies (DBVT) stake via shares and warrants - Stock Titan

Feb 17, 2026
pulisher
Feb 16, 2026

European Equities Traded in the US as American Depositary Receipts Lower Wednesday - MSN

Feb 16, 2026
pulisher
Feb 16, 2026

DBV Technologies to Participate in Biotech Summit - Intellectia AI

Feb 16, 2026
pulisher
Feb 16, 2026

DBV Technologies to Present VIASKIN® Data at AAAAI 2026 - Intellectia AI

Feb 16, 2026
pulisher
Feb 10, 2026

DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting - The Manila Times

Feb 10, 2026
pulisher
Feb 10, 2026

DBV Technologies S.A. - Via Ritzau

Feb 10, 2026
pulisher
Feb 10, 2026

Peanut allergy patch data in young children to get spotlight at AAAAI 2026 - Stock Titan

Feb 10, 2026
pulisher
Feb 09, 2026

DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit - markets.businessinsider.com

Feb 09, 2026
pulisher
Feb 09, 2026

Biotech summit to feature DBV Technologies CEO fireside chat - Stock Titan

Feb 09, 2026
pulisher
Feb 08, 2026

DBV Technologies (NASDAQ:DBVT) Upgraded at Wall Street Zen - Defense World

Feb 08, 2026
pulisher
Feb 07, 2026

DBV Technologies S.A. (NASDAQ:DBVT) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

Feb 07, 2026
pulisher
Feb 04, 2026

European ADRs Slip As Winners And Losers Split By Region - Finimize

Feb 04, 2026
pulisher
Feb 04, 2026

European ADRs Inched Higher As GSK And Telefonica Jumped - Finimize

Feb 04, 2026

Dbv Technologies Adr (DBVT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$54.26
price up icon 2.69%
$48.70
price down icon 0.25%
$99.47
price up icon 1.08%
$152.54
price up icon 3.76%
$146.74
price down icon 4.34%
ONC ONC
$319.94
price up icon 3.21%
大文字化:     |  ボリューム (24 時間):